Comparison

SAH-SOS1A European Partner

Item no. HY-P2265-100mg
Manufacturer MedChem Express
CASRN 1652561-87-9
Amount 100 mg
Category
Type Peptides
Specific against other
Citations [1]Leshchiner ES, et al. Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices. Proc Natl Acad Sci U S A. 2015;112(6):1761-1766.
Smiles [RRFFGI{Aaa}LTN{Aaa}LKTEEGN (Covalent bridge:Aaa7-Aaa11)]
ECLASS 5.1 34160400
ECLASS 6.1 34160400
ECLASS 8.0 32160409
ECLASS 9.0 32160409
ECLASS 10.0.1 32160409
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Available
Product Description
SAH-SOS1A is a peptide-based SOS1/KRAS protein interaction inhibitor. SAH-SOS1A binds to wild-type and mutant KRAS (G12D, G12V, G12C, G12S, and Q61H) with nanomolar affinity (EC50=106-175 nM), directly and independently blocks nucleotide association, impairs KRAS-driven cancer cell viability, and exerts its effects by on-mechanism blockade of the ERK-MAPK phosphosignaling cascade downstream of KRAS[1].
Shipping
Room temperature
Manufacturers Applications
Neuroscience-Neuromodulation
MolecularWeight
2187.50
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
10 mM in DMSO
Manufacturers Target
Ras
Isoform
K-Ras
Pathway
GPCR/G Protein; MAPK/ERK Pathway
Manufacturers Product type
Peptides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close